Vitamin B6 and Magnesium- A Clinical Trial on ASD Patients | NCT03963479 | Trialant

Vitamin B6 and Magnesium- A Clinical Trial on ASD Patients | NCT03963479 | Trialant

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Magnesium-Vitamin B6	Active Comparator	Magnesium (50mg) for ages 1-3 years (100mg) for ages 4-8 years (200mg) for ages 9-12 years Vitamin B6 (25mg) for ages 1-3 years (50mg) for ages 4-8 years (100mg) for ages 9-12years	Combination Product: Magnesium and Vitamin B6
Placebo	Placebo Comparator	Magnesium (50mg) for ages 1-3 years (100mg) for ages 4-8 years (200mg) for ages 9-12 years Vitamin B6 (25mg) for ages 1-3 years (50mg) for ages 4-8 years (100mg) for ages 9-12years	Combination Product: Magnesium and Vitamin B6

Interventions

Name	Type	Description	Arm Group Labels	Other Names
Magnesium and Vitamin B6	Combination Product	Magnesium and Vitamin B6 will be given to the enrolled patients for 3 months	Magnesium-Vitamin B6 Placebo

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Autism Spectrum Disorder	General observation, Cognitive Working, socialization, Communication, Sensory Dysfunction. At first a autism will be diagnosed by DSM-5 .Then the above mention criterias along with the severity will be diagnosed by Autism Diagnostic Checklist tool by a psychologist.	3 months

Secondary Outcomes

Measure	Description	Time Frame
Autism Spectrum Disorder	The Autism Diagnostic Checklist will be repeated to compare the outcomes in terms of General observation, Cognitive Working, socialization, Communication, Sensory along with the severity of the Autism.	0 month

Contacts/Locations Module

Condition Browse Module

Intervention Browse Module